Effects of a High Viscosity Dietary Fibre, as Part of a Medically Supervised Weight Management Program

Canadian Center for Functional Medicine

Status and phase

Withdrawn

Phase 3

Conditions

Obesity

Treatments

Dietary Supplement: Novel fibre supplement

Study type

Interventional

Funder types

Other

Industry

Identifiers

NCT01387126

004

Details and patient eligibility

About

The aim of this study is to investigate whether the supplementation of a medically supervised weight management program with a novel fibre supplement, improves body weight, body composition, and laboratory measurements in overweight and obese individuals. All subjects will participate in the medical weight management program however the intervention group will have 5 grams of a novel fibre supplemented to each meal while the control group will not.

Sex

All

Ages

20 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

BMI 27 - 30 Kg/m2 with 1 weight-related comorbidity and/or BMI 30 - 50 Kg/m2
Ability to provide written informed consent in accordance with Good Clinical Practice (GCP) and local legislation in English

Exclusion criteria

Medications and supplements that affect body weight and appetite
Type 2 diabetes on insulin treatment
Contraindications to low calorie diet
Any allergies to study product ingredients
Any other medical, social or geographic condition, which, in the opinion of the investigator would not allow safe completion of the protocol.